News

CNDR logo4x3

CNDR Officially Launches Canadian FSHD Dataset to Support Research and Therapy Readiness

NMD4C's BSTC launches SOP database

Basic Science Trainee Committee Launches Pre-Clinical Science Standard Operating Procedures

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Website - 2026 NMD4C Awards - Extended Jan 23 2026

2026 Awards Now Open for Nominations!

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!